C41 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.

Short description for C41 ICD 10 code:

Malignant neoplasm of bone/artic cartl of and unsp sites

Type 1 excludes for C41 ICD 10 code
  • malignant neoplasm of bones of limbs (C40.-)
  • malignant neoplasm of cartilage of ear (C49.0)
  • malignant neoplasm of cartilage of eyelid (C49.0)
  • malignant neoplasm of cartilage of larynx (C32.3)
  • malignant neoplasm of cartilage of limbs (C40.-)
  • malignant neoplasm of cartilage of nose (C30.0)

Codes
Possible back-references that may be applicable or related to C41 ICD10 Code:

Present On Admission (POA Exempt)

C41 ICD 10 code is considered exempt from POA reporting

Clinical information about C41 ICD 10 code

Cancer that starts in a bone is uncommon. Cancer that has spread to the bone from another part of the body is more common.

There are three types of bone cancer:

  • Osteosarcoma - occurs most often between ages 10 and 19. It is more common in the knee and upper arm.
  • Chondrosarcoma - starts in cartilage, usually after age 40
  • Ewing's sarcoma - occurs most often in children and teens under 19. It is more common in boys than girls.

The most common symptom of bone cancer is pain. Other symptoms vary, depending on the location and size of the cancer. Surgery is often the main treatment for bone cancer. Other treatments may include amputation, chemotherapy, and radiation therapy. Because bone cancer can come back after treatment, regular follow-up visits are important.

NIH: National Cancer Institute

The information in this box was provided by MedlinePlus.gov